Comparing methods to prevent chemotherapy-induced alopecia
Intended for healthcare professionals
Clinical Previous     Next

Comparing methods to prevent chemotherapy-induced alopecia

Lisa Dougherty Nurse consultant, Intravenous therapy The Royal Marsden Hospital Surrey

Alopecia is a common and distressing side effect of chemotherapy treatment. The condition is partially preventable by cooling the scalp prior to chemotherapy administration. The aim of this study was to compare the acceptability and efficacy of a new cooling cap called Chemocap with a home made scalp cooling system called gel pack. The results demonstrate no difference in efficacy between the systems in 170 women receiving chemotherapy containing epirubicin or doxorubicin, but a greater acceptability of Chemocap due to better fit and comfort, as well as ease of use and application.

Cancer Nursing Practice. 5, 6, 25-31. doi: 10.7748/cnp2006.07.5.6.25.c7578

Want to read more?

RCNi-Plus
Already have access? Log in

or

3-month trial offer for £5.25/month

Subscribe today and save 50% on your first three months
RCNi Plus users have full access to the following benefits:
  • Unlimited access to all 10 RCNi Journals
  • RCNi Learning featuring over 175 modules to easily earn CPD time
  • NMC-compliant RCNi Revalidation Portfolio to stay on track with your progress
  • Personalised newsletters tailored to your interests
  • A customisable dashboard with over 200 topics
Subscribe

Alternatively, you can purchase access to this article for the next seven days. Buy now


Are you a student? Our student subscription has content especially for you.
Find out more